Craig Titmus

Partner

UK & European Patent Attorney

BSc PhD (Cantab) EPA CPA

Craig holds a bachelor’s degree in molecular biology and biochemistry, as well as a PhD in biotechnology. He works on a wide variety of technical subjects, specialising in the fields of biotechnology, biochemistry and life sciences. Craig is recommended in the latest edition of The Legal 500 for being ‘highly knowledgeable’ and noted for his ability to ‘consistently meet incredibly tight deadlines’. ‘Talented biochemist’ Craig, who ‘garners rave reviews for his life sciences adroitness’ has been recommended in the IAM Patent 1000 guide for the last three years, and is praised for being a ‘lifesaver’ and a ‘true strategic partner’.

LinkedIn Email

Craig’s practice covers diverse biotechnological subject matter, with a particular focus on vaccines, diagnostics, gene therapy, therapeutic antibodies and peptides, and biofuels. Craig has significant experience of European and international patent prosecution, and coordinates global IP strategies for a range of clients including startups, SMEs, universities, large corporations and the UK Government.  

Craig gained a first class bachelor’s degree in Molecular Biology and Biochemistry at the University of Durham, where he ranked top in his year. He went on to the University of Cambridge to undertake a PhD in collaboration with a multinational crop research company, focusing on environmental stress tolerance in plants and the interfaces between metabolism and the cell cycle. During his time at Cambridge, Craig was awarded various PhD prizes within the Institute of Biotechnology. He also holds a certificate in Intellectual Property from the University of London as well as an Intellectual Property Litigation Certificate.

Craig has presented on the challenges of stem cell patentability in Europe and provided practical advice on how to obtain commercially-relevant patents in this technical field – a link to the full presentation is available here: European and US Patent Strategies for Cell Therapies.

Craig is a member of CIPA, EPI and has been appointed One Nucleus’ IP Mentor.

‘Craig Titmus pairs the slick management of patent portfolios with an ability to best even the most challenging EPO opposition proceedings. A talented biochemist and an authority on cutting-edge areas like therapeutic antibodies, he is a valuable resource to any life sciences player.’

IAM Patent 1000 (2021)

‘Craig Titmus is a “lifesaver” for his slick management of its fabric dye patent portfolio.’

Client reference, IAM Patent 1000 (2020)

‘Craig Titmus garners rave reviews for his life sciences adroitness. “He is generous with his time, experience and perspectives, incredibly knowledgeable and always helps us think through the commercial aspects of what we are trying to achieve. He has become a true strategic partner, helping clients far beyond the scope of their existing engagements”.’

IAM Patent 1000 (2019)

“Craig Titmus is highly knowledgeable and consistently meets incredibly tight deadlines.”

The Legal 500

Latest articles by Craig Titmus